Clinical impact of biliary drainage and jaundice resolution in patients with obstructive metastases at the hilum

American Journal of Gastroenterology

Volumn 98, Issue 6, 2003, Pages 1271-1277

  Van Laethem, Jean Luc ^a   De Broux, Sébastien ^a   Eisendrath, Pierre ^a   Cremer, Michel ^a   Le Moine, Olivier ^a   Devière, Jacques ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; PLATINUM DERIVATIVE;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; BILE DUCT OBSTRUCTION; BILIARY TRACT DRAINAGE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; COLON CANCER; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC THERAPY; FEMALE; HUMAN; JAUNDICE; LIVER HILUS; LIVER METASTASIS; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PRURITUS; STENT; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0038579260     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(03)00284-3     Document Type: Article

References (26)

1. Bengmark S, Hofstrom L. The natural history of primary and secondary malignant tumours of the liver. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma verified by laparotomy. Cancer 1969;23:198-202.
2. Joffe BM, Danegan WL, Watson F, Spratt JS Jr. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968;127:1-11.
3. Rougier P, Van Cutsem E, Bajetta E, et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998;352:1413-8.
4. Hortobagyi GN. Treatment of breast cancer. N Engl J Med 1998;339:974-84.
5. Ducreux M, Liguory CI, Lefebvre JF, et al. Management of malignant hilar biliary obstruction by endoscopy: Results and prognostic factors. Dig Dis Sci 1992;37:778-83.
6. Devière J, Baize M, de Toeuf J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc 1988;34:95-101.
7. Schima W, Prokesch R, Osterreicher C, et al. Biliary Wallstent endoprosthesis in malignant hilar obstruction: Long-term results with regard to the type of obstruction. Clin Radiol 1997;52:213-9.
8. Wagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprosthesis versus metal stents in the palliative treatment of malignant hilar biliary obstruction: A prospective and randomized trial. Endoscopy 1993;25:213-8.
9. Sung MW, Bruckner HW, Szobo S, Mitty HA. Extrahepatic obstructive jaundice due to colorectal cancer. Am J Gastroenterol 1988;83:267-70.
10. Marsh WH, Cunningham JT. Endoscopic stent placement for obstructive jaundice secondary to metastatic malignancy. Am J Gastroenterol 1992;87:985-90.
11. Lo CY, Lai ECS. Palliation for extrahepatic biliary obstruction by metastatic colorectal carcinoma. Am J Gastroenterol 1994;89:1852-3.
12. Valiozis I, Zekry A, Williams SJ, et al. Palliation of hilar biliary obstruction from colorectal metastases by endoscopic stent insertion. Gastrointest Endosc 2000;51:412-7.
13. Hintze RE, Abou-Rebyeh H, Adler A, et al. Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc 2001;53:40-6.
14. Zidi SH, Prat F, Le Guen O, et al. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut 2000;46:103-6.
15. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31-8.
16. Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998;47:354-62.
17. Andersen JR, Sorensen SM, Kruse A, Rokkjoer M. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989;30:1132-5.
18. Lee BH, Choe DH, Lee JH, et al. Metallic stents in malignant biliary obstruction: Prospective long-term clinical results. AJR Am J Roentgenol 1997;168:741-5.
19. Van Laethem JL, Pouzere S, Carnot T, et al. Predictive factors for successful biliary drainage and survival of patients with inoperable Klatskin's tumors. Gastroenterology 2002;122(4 suppl):A449 (abstract).
20. Cheng JL, Bruno MJ, Bergman JJ, et al. Endoscopic palliation of patients with biliary obstruction caused by non resectable hilar cholangiocarcinoma: Efficacy of self-expandable metallic Wallstents. Gastrointest Endosc 2002;56:33-9.
21. Davids PH, Groen AK, Ramos EA, et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992;340:1488-92.
22. Yeoh KG, Zimmerman MJ, Cunningham JT, Colton PB. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc 1999;49:466-71.
23. Prat F, Chafat O, Ducot B, et al. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: A practical management guideline. Gut 1998;42:76-80.
24. Saltz L, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000;343:905-14.
25. Ballinger AB, McHugh M, Catmach SM, et al. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994;35:467-70.
26. Lofts FJ, Evans TR, Moussi JL, et al. Bile duct stents: Is there an increased rate of complications in patients receiving chemotherapy? Eur J Cancer 1997;33:209-13.